companydata.dkcompanydata.dk

EP MEDICAL ApS: Financial statements 2015

CVR: 29631905

Source: annual report 2015, Danish Business Authority

01/01/2015 – 31/12/2015

EP MEDICAL ApS (CVR 29631905) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 360,840 and a net result of DKK -206,405 compared with DKK 303,170 the year before. That is a decrease of 58.3% compared with the year before. The profit margin was -57.2%. Equity in the 2015 report amounted to DKK 8,055,997. The solvency ratio was 99.1%. The company had 1 employee in the financial year.

Revenue
DKK 360,840
Gross Profit
DKK 133,842
Profit/Loss
DKK -206,405
Equity
DKK 8,055,997
Total Assets
DKK 8,131,951
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2015361 t.134 t.-206 t.8.1 mio.1
2014866 t.534 t.303 t.8.5 mio.1
2013636 t.310 t.-60 t.8.4 mio.1
2012366 t.172 t.200 t.8.7 mio.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is EP MEDICAL ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2015

EP MEDICAL ApS: The 2014 annual report is outMar 19, 2015

EP MEDICAL ApS has published its annual report for 2014. Revenue came to DKK 865,752, and the net result was DKK 303,170.

About EP MEDICAL ApS

EP MEDICAL ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2006. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named EP MEDICAL CONSULTING ApS and REFLAB HOLDING ApS. The management consists of Eva Valbjørn Sørensen. The company is owned by Per Stahl Skov and Eva Valbjørn Sørensen. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 265,299 and a net result of DKK -348,750 compared with DKK 182,500 the year before. Equity in the 2025 report amounted to DKK 5,784,791.

Source: annual report 2025, Danish Business Authority